Random

FDA

FDA Advisory Committee: Weighing Risks and Benefits of Opana ER

Weighing Risks and Benefits of Opana ER

Suzanne B. Robotti

Study Questions Safety of Silicone Breast Implants; FDA Disputes Findings

Study Questions Safety of Silicone Breast Implants

What to Know About the Right to Try Law in 2024

What to Know About the Right to Try Law in 2024

MedShadow Articles

Choices For The Terminally Ill: FDA’S Expanded Access Program Or Right To Try Act?

Jessica DiGiacinto

Family Dollar Recall

Family Dollar Products Recalled Due to Contamination

Episode 2: Talking About FDA 'Right to Try' Laws

Episode 2: Talking About FDA ‘Right to Try’ Laws

Medshadow Staff

Quick Hits: FDA About MRI Contrast Agent Problem And More

Quick Hits: FDA About MRI Contrast Agent Problem And More

Transforming U.S. Drug Policy, equitable healthcare

MedShadow Articles

Opinion: Transforming U.S. Drug Policy for Better Drug Safety

Suzanne B. Robotti

man inspecting drug manufacturing lab

Unannounced Inspections of Drug Manufacturers Could Improve Drug Safety — If It Actually Happens

News FDA Watch FDA

Will FDA Ban Electric Shock Therapy?

Tianeptine Dangerous, FDA Says

Antidepressants and Anxiety Meds

Tianeptine Dangerous, FDA Says

Part 2: The FDA Cracks Down On Stem Cell Therapy

Regenerative Medicine Series

Part 2: The FDA Cracks Down On Stem Cell Therapy

FDA Advisory Committee and FDA Drug Approval

The Increasing Influence of Big Pharma on FDA Drug Advisory Committees

FDA

Dear FDA: Do More When Nuplazid Has Issue After FDA Approval

Light Therapy May Ease Cancer Symptoms

News FDA Quick Hits

Quick Hits: Light Therapy May Ease Cancer Symptoms

Migraine Drugs and High Blood Pressure, Circulation Problems , woman about to take tablet

FDA SIDE EFFECTS UPDATE: Migraine Drugs and High Blood Pressure, Circulation Problems

The FDA Has It Wrong on Kratom: How the Herb is Helping People

UK drug company Glaxo ‘paid bribes to Polish doctors’

Medshadow Staff

FDA Requiring Long-Term Research of OxyContin Use

FDA Requiring Long-Term Research of OxyContin Use

Suzanne B. Robotti

NSAID Side Effects Lead To Stronger FDA Warnings

NSAID Side Effects Lead To Stronger FDA Warnings

FDA

Recent Drug Approval Highlights Less Stringent FDA Criteria

Load More

x

x